Obesity Week 2024 covered a range of innovative topics in obesity research. What did you find most impactful? In case you missed it, make sure to check out our poster, “Clinical Trial Design: Body Composition Assessments in Obesity,” which shares insights into the critical role body composition assessments play in obesity clinical trial design: https://lnkd.in/ekaDH-xj

We're honored to be recognized as a finalist in Fierce Pharma's 2024 Fierce Diversity, Equity, & Inclusion Awards in the category of Innovative DEI Training and Education programs. This recognition underscores our passion for creating a more equitable and inclusive workplace. We're grateful to our employee-led Diversity Council and all team members for their tireless efforts in driving positive change. Congratulations to all the finalists! View the full list here: https://ow.ly/M3io50U1JGa

Join us in Boston on November 10-13th at the 15th CNS Summit, which brings together leading pharma and biotech executives, CROs, investigator sites, patient advocacy groups, and other stakeholders to discuss the latest innovations in clinical research. On November 12th, Melissa A. Carbo, M.S., LPC, Kenneth Williams, Madelyn Moberg, and Rolana Avrumson will showcase how collaboration can drive novel solutions in participant selection and improve trial outcomes for those affected by major depressive disorder.     Make sure to stop by our poster session to learn more about this impactful research and engage in meaningful discussions with our experts.

Did you know that patient-led organizations are now playing a larger role than ever in advancing rare disease research? By developing registries, funding studies, and collaborating with regulatory bodies, they’re helping make rare diseases viable targets for drug development. Read our latest blog by Juliane Mills to learn more about the critical role of patient-led research in rare diseases and the impact of these partnerships: https://ow.ly/ruTr50TZxbg

Following the fantastic 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference, we’re proud to share our tailored approach to Alzheimer’s research. At Worldwide, we’re dedicated to advancing treatment options for AD, conducting 49 studies across over 35 countries utilizing our deep scientific expertise, strong site relationships, industry-leading rater training, and more. Learn more about our proven approach in our fact sheet: https://ow.ly/YPbG50TZqHw

At Worldwide, we specialize in designing and executing customized studies that drive your drug development forward. With our co-located Clinical Pharmacology Unit (CPU) and bioanalytical lab, we’re here to help give your Phase I study its best chances of success. Learn more about our Phase I capabilities today: https://ow.ly/7VhP50TXxAM

Collecting patient-reported outcomes is pivotal for clinical trial success, but it can come with its own unique set of challenges. That’s why we’ve created our latest guide, which helps you navigate selecting which diary design, choosing the right format, and understanding regulatory requirements. Download your copy today to take the first step towards optimized patient diary solutions: https://ow.ly/XqrK50TXsPP

We're thrilled to share that Steve Chriscoe, our Vice President of Oncology Project Management, will be the opening keynote speaker at the inaugural COG: CRO Summit on December 3rd, 2024. Secure your spot today to check out his presentation, which will address critical strategies for successful CRO and sponsor partnerships: https://lnkd.in/ekhF5ymd

This October, we observe World Mental Health Awareness Month, a time to encourage open conversations about mental health challenges. At Worldwide, we prioritize mental health as much as physical health for our team members, and we understand the critical role mental health plays in clinical research and patient care. Check out our video with Kenneth Williams that emphasizes the importance of mental health awareness and the role we all play in supporting each other: https://ow.ly/YRcY50TVQZ8

Is your cardiometabolic drug development program ready to achieve its full potential? With a network of global experts, in-depth regulatory insights, and access to key opinion leaders, Worldwide can help guide you from strategic planning to post-marketing. Check out our fact sheet to learn more about our cardiometabolic expertise: https://ow.ly/BsyP50TWoxN